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TGF-b type II receptor (Tgfbr2) signaling plays an essential role in joint-element development. The Tgfbr2PRX-1KO
mouse, in which the Tgfbr2 is conditionally inactivated in developing limbs, lacks interphalangeal joints and
tendons. In this study, we used the Tgfbr2-b-Gal-GFP-BAC mouse as a LacZ/green fluorescent protein (GFP)-
based read-out to determine: the spatial and temporally regulated expression pattern of Tgfbr2-expressing cells
within joint elements; their expression profile; and their slow-cycling labeling with bromodeoxyuridine (BrdU).
Tgfbr2-b-Gal activity was first detected at embryonic day (E) 13.5 within the interphalangeal joint interzone. By
E16.5, and throughout adulthood, Tgfbr2-expressing cells clustered in a contiguous niche that comprises the
groove of Ranvier and the synovio-entheseal complex including part of the perichondrium, the synovium, the
articular cartilage superficial layer, and the tendon’s entheses. Tgfbr2-expressing cells were found in the synovio-
entheseal complex niche with similar temporal pattern in the knee, where they were also detected in meniscal
surface, ligaments, and the synovial lining of the infrapatellar fat pad. Tgfbr2-b-Gal-positive cells were positive for
phospho-Smad2, signifying that the Tgfbr2 reporter was accurate. Developmental-stage studies showed that
Tgfbr2 expression was in synchrony with expression of joint-morphogenic genes such as Noggin, GDF5, Notch1,
and Jagged1. Prenatal and postnatal BrdU-incorporation studies showed that within this synovio-entheseal-
articular-cartilage niche most of the Tgfbr2-expressing cells labeled as slow-proliferating cells, namely, stem/
progenitor cells. Tgfbr2-positive cells, isolated from embryonic limb mesenchyme, expressed joint progenitor
markers in a time- and TGF-b-dependent manner. Our studies provide evidence that joint Tgfbr2-expressing cells
have anatomical, ontogenic, slow-cycling trait and in-vivo and ex-vivo expression profiles of progenitor joint cells.
Introduction
TGF-b type II receptor (Tgfbr2 a.k.a. TbRII) is the onlyTgfbr that is capable of binding all the TGF-b isoforms
and eliciting a functional signal classically through the
R-Smad-dependent pathway [1,2]. It has been difficult
to study the expression pattern of Tgfbr2 because of the lack
of reliable antibodies for immunohistochemistry (IHC) and
probes for mRNA in situ hybridization (ISH) analyses.
Germline null Tgfbr2 mice exhibit early embryonic lethality,
making it impossible to study Tgfbr2’s role in organogenesis.
To determine the role of TGF-b signaling in early limb de-
velopment, we have previously generated and characterized
the Tgfbr2PRX-1KO mouse in which the Tgfbr2 is conditionally
inactivated in developing limbs [3,4]. We found that
Tgfbr2PRX-1KO mice fail in the formation of the joint interzone,
the first morphogenic event in joint development, and thus
lack interphalangeal joint development [3]. We also found
that Tgfbr2 signaling regulates expression of key joint mor-
phogenic factors such as Noggin, GDF5, and Jagged1, lead-
ing to the conclusion that Tgfbr2 signaling is the ‘‘port-of-
entry’’ in joint development [3]. More recently, Pryce et al.
found that the Tgfbr2PRX-1KO mouse lacks tendons and liga-
ments in several joints and we have observed the lack of
meniscal development and synovial abnormalities in the knee
joint [4,5]. These findings indicate that Tgfbr2 signaling is
essential for the development of critical joint elements and led
us to investigate the expression pattern of Tgfbr2-expressing
cells and their characterization as joint progenitors.
Although molecular and genetic studies have revealed
that emerging joints and interzone cells express a number of
genes that are critical in joint development, such as GDF5,
Wnt9a, and Noggin, there is still inadequate knowledge of
interzone cell function; furthermore, it is unclear whether
such joint progenitors are present in postnatal joints [6–8].
Putative adult joint progenitors have been identified based
on marker expression, such as Notch1 and chondroitin
sulfate sulfation motifs [9–11]. However, the nature and
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morphogenic abilities of these adult cell populations remain
even less defined than cells within developing joints. Cell
tracking of embryonic GDF5 joint cells showed that cells
remained topographically confined in specific joint sites over
time and gave rise to articular cartilage, synovial lining, and
tendons [12]. In these mice the nature of the Gdf5-driven Cre
is followed by irreversible activation of reporter activity;
therefore, it is impossible to establish exactly what devel-
opmental relationship (prenatal vs. postnatal) exists among
the reporter-positive cell populations [12].
Potential joint progenitors have also been identified based
on specific localization within the joint. The groove of Ran-
vier, the infrapatellar fat pad, and the superficial layer of the
articular cartilage are regions where joint progenitor/stem
cells have been hypothetically allocated [10,13–17]. The
groove of Ranvier is a fibrocartilagenous circular structure
constituted by several layers of cells surrounding the long-
bone epiphyseal growth plates, extending around the de-
veloping joint and becoming part of the perichondrium/
periosteum in adulthood [16,18,19]. Recently, the groove of
Ranvier has been found to be a niche for postnatal slow-
proliferating joint stem/progenitor cells [13]. The synovio-
entheseal complexes also called ‘‘enthesis organs’’ are found
in numerous joints, including the interphalangeal and knee
joints and have recently received particular attention because
of their involvement during osteoarthritis (OA) and spon-
dylarthritis [20–24]. When intra-articular the complex should
be more correctly termed synovio-entheseal-articular carti-
lage complex [20].
Here, we generated the Tgfbr2-b-Gal-GFP-BAC transgenic
mouse to study the role of Tgfbr2-expressing cells.
The Tgfbr2-b-Gal-GFP-BAC mouse carries b-galactosidase
(b-Gal) and green fluorescent protein (GFP) as reporters
for histological imaging and fluorescence-activated cell
sorting (FACS) for Tgfbr2 expression [3]. Using the Tgfbr2-
b-Gal-GFP-BAC we characterized (1) the dynamic and spatio-
temporally regulated expression pattern of Tgfbr2-expressing
cells from embryonic interphalangeal and knee joint devel-
opment throughout adulthood; (2) the niches for the Tgfbr2-
expressing cells that were maintained from prenatal to postnatal
in small as well as large joints; (3) the Tgfbr2-expressing cells
as slow-cycling cells coexpressing Jagged1, Notch1, Noggin,
and GDF5; (4) the developmental-dependent gene expres-
sion profile of freshly isolated Tgfbr2-expressing cells; (5) the
TGF-b responsiveness of isolated Tgfbr2-expressing cells
leading to the regulation of stem-cell-related genes, articular
cartilage, synovium, and tendon/ligament gene expression.
Materials and Methods
Mice
The Tgfbr2-b-Gal-GFP-BAC transgenic mice were gener-
ated as previously reported using the mouse bacterial-arti-
ficial-chromosome (BAC) clone RP24-317C21 containing the
Tgfbr2 obtained from the Children’s Hospital Oakland Re-
search Institute and using homologous recombination, a
GFP-IRES-b-Gal-GEO cassette was inserted into the Tgfbr2-
BAC at the endogenous Tgfbr2 translational start site to have
b-Gal and GFP as imaging reporters for Tgfbr2 expression
under the control of the promoter and endogenous (within
195.8 kb) Tgfbr2 gene regulatory sequences [3]. The
Tgfbr2Prx1KO conditional knock-out mice were generated as
previously reported by crossing Tgfbr2flox/flox homozygous
females, with males Prx-1-Cre (provided by C. Tabin, Har-
vard University) [3,25]. All animal protocols and procedures
were approved by the animal care committee of University
of North Carolina at Chapel Hill.
Detection of b-Gal activity in whole-mount embryos,
paraffin sections, and frozen sections
Tgfbr2-b-Gal-GFP-BAC embryos were obtained from timed
pregnancies using the morning of the vaginal plug appear-
ance as embryonic day (E) 0.5. Adult specimens were ob-
tained from Tgfbr2-b-Gal-GFP-BAC mice at the indicated
postnatal (P) ages. Skin was removed from mice at and be-
yond E15.5 before LacZ staining. For whole-mount LacZ
staining, dissected embryonic limbs were prefixed in 4%
phosphate buffered saline (PBS)-buffered paraformaldehyde
(PFA)-tween(0.1%) for 0.5–1 h at 4C and dissected adult
limbs in 4% PBS-buffered-PFA-tween(0.1%) for 1–2 h at 4C;
specimens were washed three times with PBS tween(0.1%)
for 10–30 min each time and incubated in 0.1% X-gal reaction
(buffer at pH 7.5) overnight in the dark at 37C, rinsed in
PBS, and postfixed in 4% PFA solution 0.5–2 h at 4C; spec-
imens were paraffin-embedded, histological sections were
obtained and counterstained with Fast Red as previously
reported [3]. For frozen section LacZ staining, dissected
limbs were fixed with 4% PFA for 1 h, then treated and
embedded in PBS-sucrose and OCT-sucrose, and cut in sec-
tions (12-mm thickness) using a MICROM HM505E cryostat
microtome (ThermoFisher); sections were hood-dried, re-
fixed with 4% PBS-buffered-PFA-glutaraldehyde(0.5%) for
3–4 min, washed with PBS twice, and then stained with X-gal
reaction buffer as described above.
Bromodeoxyuridine incorporation studies
We performed three distinct analyses of bromodeoxyur-
idine (BrdU) incorporation: the first (termed Study 1) aimed
at labeling slow-proliferating cells from the embryonic
through early postnatal life. The second study and the third
study (termed Study 2 and Study 3) were to label cells at
two postnatal lifetime points. For Study 1, mice received
BrdU (Sigma-Aldrich) during the prenatal life as provided
to pregnant mothers through daily supply of drinking
water (0.4 mg/mL) from E15.5 to P0; pups were sacrificed
at P7, P14, and P28. A total of 21 pregnant Tgfbr2-b-Gal-
GFP-BAC mice were used for this study. For Study 2, P6-
week (P6w) old Tgfbr2-b-Gal-GFP-BAC mice were exposed
to BrdU, through daily supply of drinking water (0.4 mg/
mL), for 14 days; BrdU-exposed animals were sacrificed
(three mice per time point) at 7, 14, 21, and 28 days after
the last BrdU administration. For Study 3, P20-day (P20d)
old Tgfbr2-b-Gal-GFP-BAC mice were exposed to BrdU,
through daily supply of drinking water (0.4 mg/mL), for 30
days; BrdU-exposed animals were sacrificed (three mice per
time point) at 52 days after the last BrdU administration.
This last study used a timetable similar (we used an even
longer washout period) to the one recently employed by
Kurth et al. to study slow-proliferating cells in joints [26].
Experimental animals were kept in separate cages to mon-
itor their BrdU/water intake.
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Histology, IHC, ISH, and immunofluorescence
Tissue sections were subjected to IHC as previously re-
ported [3]. The following primary antibodies were used: anti-
phosphorylated-Smad2 (p-Smad2) (3101S, Cell Signaling,
1:100 dilution), Notch1 (Sc-6014, Santa Cruz Biotechnology,
1:100 dilution), Jagged1 (Sc-6011, Santa Cruz Biotechnology,
1:150 dilution), Noggin (AF719, R&D Systems, 15 mg/mL),
GDF5 (AF853, R&D Systems, 10 mg/mL), Tenascin C
(MAB3358, R&D Systems, 10mg/mL), TGF-b1 and TGF-b2
(Sc-146 and Sc-90, Santa Cruz Biotechnology, 1:100 dilution),
Tgfbr2 (Sc-400, Santa Cruz Biotechnology, 1:50 dilution), and
BrdU (Ab8955, Abcam, 1:250 dilution). To obtain antigen
retrieval, for BrdU-IHC, sections were treated with 0.05%
trypsin-ethylenediaminetetraacetic acid (EDTA) for 3–5 min;
for pSmad2-IHC, sections were boiled in 10 mM sodium
citrate solution for 10 min; for TgfbR2-IHC, sections were
boiled in 1· PBS for 5 min; after cooling down to room
temperature (if needed) sections were subjected to IHC as
previously reported [3]. Immunostaining was visualized
using the ABC staining system (Vector Laboratory) and a
peroxidase substrate (DAB Chromagen). To visualize carti-
lage, sections were subjected to Safranin O staining as previ-
ously reported [3]. ISH studies were performed as previously
reported using a DIG-labeled probe for Tgfbr2 provided by
S.K.D. (Cincinnati Children’s Hospital, Cincinnati, OH) [3].
For BrdU-GFP immunofluorescence (IF) analysis, the fol-
lowing primary antibodies were used: BrdU (Ab8955, Ab-
cam, 1:250 dilution) and GFP (GFP-1020, Aves Lab, 1:500
dilution). Sections were treated with PBS containing 50 mM
ammonium chloride (2 · 5 min) to quench autofluorescence
and followed with Image-iT-Fx signal enhancer (A31629;
Invitrogen) treatment to block background. Detection of
GFP-Ab complex was by Alexa Fluor secondary antibody
(Alexa 555 Goat anti-chicken). After nuclear counterstaining
using 4¢,6-diamidino-2-phenylindole (DAPI), sections were
mounted and analyzed with a Zeiss 510 META laser scanning
confocal microscope. Slides were then placed into 1· PBS for
20 min and cover slips were carefully removed. Sections were
washed in 1· PBS for 2 · 5 min and then subjected to BrdU IF.
To obtain antigen retrieval, sections were treated with 2 N
hydrochloric acid at 37C for 20 min and 0.5% trypsin-EDTA
for 5 min; detection of BrdU-Ab Alexa Fluor secondary anti-
body (Alexa 488 Goat anti-mouse). Sections were mounted
and analyzed with a Zeiss 510 META laser scanning confocal
microscope. GFP, DAPI, and BrdU signals were overlaid
using Photoshop CS2 (Adobe).
Microscope imaging and imaging processing
Histological, IHC, and LacZ staining images were taken
using either BX51 or 1X70 or SZX16 microscopes (Olympus)
equipped with a digital camera (DP71; Olympus); they were
imported into Photoshop CS2 (Adobe) and formatted and
shown in two ways: (1) without using any imaging en-
hancement and (2) using pseudocolor image processing as
described by Basu et al. and Sedgewick [27,28]. In particular,
for pseudo-colored images, IHC micrographs were pro-
cessed using Adobe Photoshop CS2; distinct color ranges
corresponding to LacZ, IHC, and both LacZ and IHC-
positive signals were clearly separated using histogram
analysis and color-replaced as indicated [27,28].
Tgfbr2-b-Gal-GFP-BAC transgene copy
number estimation
The copy number of Tgfbr2-b-Gal-GFP-BAC transgene
was determined in two independently generated transgenic
mouse lines (termed line #23 and line #37). Liver and tail
tissues were dissected from E1.5 Tgfbr2-b-Gal-GFP-BAC
embryos from line #23 and line #37 (two embryos per line)
and genomic DNA was extracted as reported by Shi et al.
[29]. Copy number estimates were derived from DCt values
for standard curve estimates using a modified version of
the method and primer sequences previously described
[30]. Genomic DNA was quantified using the Qubit fluo-
rometer and reagents (Invitrogen). Quantitative real-time
polymerase chain reaction (qRT-PCR) was performed using
a CFX96 thermocycler and SsoFast polymerase mix (Bio-
Rad). To generate the standard curve, twofold dilutions of
plasmid DNA (pcDNA3.1) were spiked into mouse geno-
mic DNA at known diploid copy-number equivalents as
previously described [30]. Briefly, 2mL of genomic DNA
(20 ng) or copy number standards were analyzed in a 10mL
reaction volume with the neomycin (Neo) resistance (Neo
gene located at b-geo insertion in the BAC vector) and Jun
(internal control) primer sets. All reactions were performed
in triplicate. Copy number estimates for Neo were derived
using the triplicate DCT value relative to the internal
Jun genomic control and compared to the DCt values of
standard-curve values.
Cell isolation and flow cytometry
Embryonic mesenchyme digit cells were obtained as previ-
ously described [3]. Briefly, distal tips of the autopods of either
E13.5 or E14.5 Tgfbr2-b-Gal-GFP-BAC embryos were dissected
and subjected to dispase (Biosciences) digestion. Undissociated
cells were removed and single cells sorted (MoFlo, Beckman)
based on GFP fluorescence. For mesenchymal stem cell (MSC)
and hematopoietic cell marker analyses, cells were labeled with
phycoerythrin (PE) anti-mouse CD44, CD29,CD73,CD105,
CD45,CD34,CD11b (eBiosciences). Cells were then subjected to
PE and GFP flow cytometry analysis (MoFlo, Beckman). Data
were analyzed using the Summit software (Beckman Coulter).
qRT-PCR gene expression analysis in isolated
Tgfbr2-positive cells
Total RNA was obtained from freshly isolated Tgfbr2-
positive mesenchymal digit cells or from Tgfbr2-positive
cells cultured as micromasses as previously reported [31]
that were treated with or without TGF-b1 (20 ng/mL)
for 16 h. mRNA was directly reverse transcribed to
cDNA (mMACS Oligo(dT) MicroBeads Miltenyi) and
subjected to qRT-PCR as previously described [31]. PCR
primers and conditions are listed in Supplementary Table S1
(Supplementary Data are available online at www
.liebertpub.com/scd).
Statistical analysis
Data are presented as mean – SD. Statistical differences
between groups were assessed by unpaired Student’s t-test
(GraphPad Prism Software). Statistical significance was set at
P < 0.05.
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Results
Tgfbr2-expressing cells localize in specific niches
that are maintained throughout development
and postnatal life
We used the Tgfbr2-b-Gal-GFP-BAC mouse, containing b-
Gal as a reporter for histological imaging, to determine the
temporal and spatial expression pattern of Tgfbr2 during
joint development and postnatal life. E12.5, E13.5, E14.5, and
E16.5 Tgfbr2-b-Gal-GFP-BAC embryos were subjected to
LacZ staining. As shown in Fig. 1, an intense temporally and
spatially dependent Tgfbr2-b-Gal expression/activity was
noted within the developing limbs. Within the forelimbs, the
b-Gal activity was first evident (E12.5) at the prospective
elbow site, by E13.5 in the metacarpal region and developing
interzone of the digits and by E16.5 was well defined in the
interphalangeal joints (Fig. 1). b-Gal activity within the hin-
dlimbs was delayed compared to the forelimbs by approxi-
mately 1 day, yet becoming similar at E14.5 (Fig. 1).
Performing extensive multiplanar sectioning of the forelimbs
through the three main planes (sagittal, coronal, and trans-
verse) (Fig. 2A) at different embryonic stages (E13.5, E14.5,
and E16.5), we have rendered a three-dimensional schematic
reconstruction of Tgfbr2-b-Gal-expressing cell distribution
within the joints (Fig. 2B). We found that at the site where the
interzone begins to develop (E13.5), Tgfbr2-expressing cells
were initially limited to cells in the dorsal and ventral regions
(Domain 1, in Fig. 2B). This domain gradually extended
laterally and from distal to proximal as part of the peri-
chondrium surrounding the joints and the distal part of the
growth plate (Fig. 2A, B). b-Gal activity was undetectable in
the central region of the interzone (Fig. 2). Starting at E13.5,
we also found Tgfbr2-b-Gal expression/activity along the
developing tendons (Domain 2, Fig. 2A, B). This expression
domain gradually decreased from E14.5 to E16.5, where it
was found primarily surrounding the surface of developing
tendons.
To determine whether the Tgfbr2-b-Gal expression/
activity pattern was consistent among different lines, we
examined the expression in two distinct Tgfbr2-b-Gal-GFP-
BAC lines (termed, respectively, line #23 and line #37). As
shown in Supplementary Fig. S1A, we found that the ex-
pression pattern within the whole-mount hindlimb and digit
sections was similar in the two lines although in line #37 the
signal was fainter. To determine whether the expression in-
tensity was related to the BAC transgene copy numbers, we
quantified by qRT-PCR the BAC copy numbers in the ge-
nomic DNA of liver and tail specimens obtained from two
mice of line #23 and two mice of line #37. As shown in
Supplementary Fig. S1B we found that compared to line #37,
line #23 had higher copies of the BAC transgene both in the
liver as well as in the tail.
To determine whether Tgfbr2-b-Gal expression/activity
pattern was dependent on the LacZ staining modality, we
performed whole-embryo LacZ staining followed by paraffin
embedding and sectioning as well as frozen sectioning fol-
lowed by LacZ staining using contralateral specimens from
the same mouse. As shown in Supplementary Fig. S1C, we
found that an identical Tgfbr2-b-Gal expression/activity
pattern was detected by the two LacZ staining modalities.
To further verify the robustness of our Tgfbr2-b-Gal re-
porter system, we subjected LacZ-stained sections from
FIG. 1. Analysis of TGF-b





hindlimbs isolated from Tgfbr2-
b-Gal-GFP-BAC embryonic day
(E) 12.5, E13.5, E14.5, and E16.5
embryos were subjected to
whole-embryo LacZ staining.
At E12.5, reporter activity is
visible in the elbow. At E13.5
and E14.5, reporter activity is
noticeable in the incipient in-
terphalangeal joints, metacar-
pal/metatarsal regions, and
elbow/knee sites. By E16.5,
reporter activity becomes more
defined at the interphalangeal,
knee, and elbow joint sites.
Studies were performed in at
least three embryos at each
time point.
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FIG. 2. Characterization of spatial and temporal domains for Tgfbr2-expressing cells in embryonic interphalangeal joints.
To obtain a three-dimensional map of the Tgfbr2-expressing cells within developing interphalangeal joints, we subjected
forelimb digits from E13.5, E14.5, and E16.5 Tgfbr2-b-Gal-GFP-BAC embryos to LacZ staining; the entire specimens were then
sectioned through each of the three spatial planes: coronal, transverse, or sagittal. Three-dimensional reconstruction was
rendered by analyzing all the sequential sections from each sectioning plane. (A) Depicts two representative examples of
sections of digits from each of the sectioning planes from E13.5, E14.5, and E16.5 Tgfbr2-b-Gal-GFP-BAC embryos; coronal
sections were stained with Fast Red. Red arrows indicate reporter activity sites. (B) Three-dimensional reconstructions of the
Tgfbr2-b-Gal activity/expression pattern based on the sectioning analyses. Studies were performed in at least two embryos at
each time point and for each sectioning plane. Scale bars: 200mm.
FIG. 3. Time-dependent expression pattern of Tgfbr2 in postnatal interphalangeal joints. Forelimbs from postnatal Tgfbr2-
b-Gal-GFP-BAC mice [postnatal (P) 7, P14, P21, P35, P3 months (m), P6m, P9m, and P12m old] were processed for whole-
mount LacZ staining. Red arrows show sites of reporter activity. Studies were performed in at least two mice at each time
point.
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Tgfbr2-b-Gal-GFP-BAC to IHC, respectively, for p-Smad2 and
Tgfbr2 (Supplementary Fig. S2A) and sections from
Tgfbr2Prx1KO and control mice (Tgfbr2flox/flox), respectively,
to IHC for Tgfbr2 and ISH for Tgfbr2 (Supplementary Fig.
S2B). We found that Tgfbr2-b-Gal expression/activity sites
overlapped with immunostaining for p-Smad2 (red arrows
in Supplementary Fig. S2A, upper panel) and for Tgfbr2 (red
arrows in Supplementary Fig. S2A, lower panel) but in ad-
dition IHC for Tgfbr2-immunostained cells within the
growth plate and in the middle of the joint (black arrows in
Supplementary Fig. S2A, lower panel), those regions were
not identified by LacZ staining and by p-Smad2 IHC. To
determine whether those regions were either related to a
nonspecific staining of the Tgfbr2 antibody or failure of the
LacZ staining/reporter system, we performed IHC for
TgfbR2 in Tgfbr2Prx1KO and Tgfbr2flox/flox mice. As shown in
FIG. 4. Tgfbr2 expression clusters in a well-defined joint niche comprising the groove of Ranvier and the synovio-entheseal-
articular cartilage complex. Sagittal sections of proximal interphalangeal joint (A) and metacarpo-phalangeal joint (B) from
P2w Tgfbr2-b-Gal-GFP-BAC mice subjected to LacZ and Safranin O staining. Tgfbr2 expression was clustered in a specific
niche (square marked region) that comprised the groove of Ranvier (arrow 1), the articular cartilage (arrow 2); the synovium
(arrow 3), and entheses (arrow 4). Tgfbr2 expression was also found in the surface cells of the tendons (arrow 5) and the
synovial lining (arrow 6). Studies were performed in at least three mice. Scale bars: 200 mm.
FIG. 5. Expression pattern of Tgfbr2 in embryonic and postnatal knee joint. (A) Hindlimbs isolated from Tgfbr2-b-Gal-GFP-
BAC mice (from E13.5 to P14) were processed for whole-mount LacZ staining. At E13.5, reporter activity is visible in two
minute domains indicated by red and green arrows. By E14.5 the two domains coalesced and by E16.5 to P1, reporter activity
gradually increased and was maintained at P14. (B) Knees from E14.5, E16.5, P1, and P7 Tgfbr2-b-Gal-GFP-BAC mice were
LacZ stained, sagittal sections obtained, and counter-stained with Fast Red. Tgfbr2 expression localized within the synovio-
entheseal-articular cartilage complex including part of the articular cartilage (arrow 1), the synovium (arrow 2), entheses (arrow
3), and adjacent perichondrial tissue (arrow 7). In addition to this niche, we found expression within the superficial cells of
tendons and ligaments (arrow 4); synovial regions outside of the synovio-entheseal-articular cartilage complex (arrow 5);
superficial layer of the menisci (arrow 6). M, meniscus; F, femur; T, tibia; P, patella; PL, patellar ligament; CL, cruciate
ligament. Studies were performed in at least three mice from each time point. Scale bars: 200mm.
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Supplementary Fig. S2B (upper panels) in the Tgfbr2Prx1KO
(that is supposed to be the negative control for the antibody)
Tgfbr2 IHC immunostained cells within the growth plate
and some even within the center of the joint. Similarly, we
found that ISH for Tgfbr2 detected a positive signal within
the growth plate in Tgfbr2Prx1KO (Supplementary Fig. S2B,
lower panel); of note, the overall signal in Tgfbr2flox/flox was
very low.
We extended our Tgfbr2-b-Gal expression/activity anal-
ysis to postnatal limbs from 7-day to 12-month-(P12m)-old
mice. We found that the expression of Tgfbr2 localized in the
interphalangeal joint region consistent with Domain 1 found
in embryonic stages and expression was age related, be-
coming more confined to the joint and gradually decreasing
but still present at 12 months of age (Fig. 3). Figure 4 shows
Tgfbr2-b-Gal expression/activity in sections, respectively, of
the proximal interphalangeal joint (Fig. 4A) and metacarpo-
phalangeal joint (Fig. 4B) of postnatal 2-week-old (P2w)
Tgfbr2-b-Gal-GFP-BAC mice. We found that Tgfbr2 expres-
sion clustered in a well-defined niche (square marked in Fig.
4A, B) including the groove of Ranvier (arrow 1) and con-
tiguously the synovio-entheseal-articular cartilage complex
comprising part of the articular cartilage (arrow 2); the sy-
novium (arrow 3), and entheses (arrow 4). In addition to this
niche we found expression of Tgfbr2 in the surficial cells of
the tendons (arrow 5) and the synovial lining (arrow 6). We
then evaluated the expression pattern of Tgfbr2 in the em-
bryonic and postnatal knee joint. As shown in Fig. 5A, we
found that the expression in the knee joint that started at
E13.5 was initially limited to two minute domains within the
dorsal side (indicated by red and green arrows in Fig. 5A). At
E14.5 we noted the two domains coalesced, assuming a
FIG. 6. Colocalization of
Tgfbr2 with joint and pro-
genitor makers in E16.5 in-
terphalangeal joints. Limbs
from E16.5 Tgfbr2-b-Gal-GFP-
BAC mice were LacZ stained.
Sagittal and transverse sec-
tions were subjected to im-
munohistochemistry (IHC)
using Jagged1, Notch1,
Noggin, GDF5, TGF-b1, TGF-
b2, and Tenascin C antibodies;
immunostaining was visual-
ized using a peroxidase-based
DAB system (IHC-DAB). Data
are presented either as un-
modified images (left upper
and lower panels related to
each IHC study) or after
pseudocolor image processing
(right upper and lower panels
related to each IHC study) to
highlight the signals of either
single-stained cells (in blue for
single LacZ signal and red for
single IHC-DAB signal) or
double-stained cells (in green
for LacZ + IHC signal). For
unmodified images light blue
represents single LacZ posi-
tive signal, light brown pres-
ents single IHC-DAB positive
signal, and dark brown repre-
sents double LacZ + IHC-DAB
positive signal. Red arrows in-
dicate regions for double-
positive LacZ + IHC-DAB sig-
nals. Studies were performed
in at least three sections for
each sectioning plane ob-
tained from at least two mice
at each time point. Scale bars:
100mm.
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cylindrical domain (green and red arrows). The expression of
Tgfbr2 extended with age up to P1 and was maintained in
postnatal life (Fig. 5A). Sectioning of LacZ-stained knee joints
at different prenatal and postnatal stages showed that Tgfbr2
expression was consistently found in some of the anatomical
regions in which it was detected in the interphalangeal joints
(Fig. 5B). Starting at E16.5 and more defined at P1 and P7, we
found that Tgfbr2 expression localized within the synovio-
entheseal-articular cartilage complex including part of the
articular cartilage (arrow 1), the synovium (arrow 2), en-
theses (arrow 3), and part of the perichondrial tissue (arrow 7
in Fig. 5B). A larger magnification of the expression of Tgfbr2
within the niche comprising the synovio-entheseal-articular
cartilage complex is presented in Supplementary Fig. S3A.
FIG. 7. Characterization of Tgfbr2-expressing cells as slow-cycling joint progenitor cells at prenatal stage (Study 1).
Bromodeoxyuridine (BrdU) Study 1 is schematically presented in (A); mice received BrdU during the prenatal life provided
per os to Tgfbr2-b-Gal-GFP-BAC pregnant mothers from E15.5 to P0; P14 and P28 Tgfbr2-b-Gal-GFP-BAC pups were LacZ stained.
At least three mice for each time point were analyzed. (B) Depicts a representative section of P14 specimen; 10 · (left upper
quadrant) (a) and 40 · (b–d) magnifications of the square-marked regions (other quadrants). (B¢) Depicts a representative section of
P28 specimen; (left upper quadrant) (a) and 40 · (b–d) magnifications of the square-marked regions (other quadrants). LacZ-stained
dissected digits were sectioned (sagittal plane) and subjected to IHC for BrdU using a peroxidase-based system (see the Materials
and Methods section). Tgfbr2-b-Gal single-positive cells are shown in blue. Black/dark brown shows positive cells for IHC. Blue cells
with black/dark brown nuclear indicates BrdU + LacZ double-positive cells (red arrows). Tgfbr2-LacZ/BrdU double-positive cells
localized within specific niches (marked with red dashed line) in particular the groove of Ranvier (R1) and contiguously the
synovial-entheseal-articular cartilage complexes (R2 and R3) and the tendons (R4) of the interphalangeal joints labeling as slow-
proliferating cells. Red arrows indicate regions of double-positive cells; green arrows show regions of BrdU single-positive cells. Scale
bars: 200mm.
FIG. 8. Characterization of Tgfbr2-expressing cells as slow-cycling joint progenitor cells at postnatal stage (Studies 2–3).
BrdU Study 2 is schematically presented in (A); P6w old Tgfbr2-b-Gal-GFP-BAC mice received oral BrdU, for 14 days and were
sacrificed 7, 14, and 21 days after the last BrdU administration. At least three mice for each time point were analyzed. (B) Depicts
representative sections of P8w + 14d specimens; 10 · (a) and 40 · magnifications of the square-marked regions (b–d). (B¢) Depicts
representative sections of P8w + 21d specimen; 10 · (e) and 40 · (f–h) magnifications of the square-marked regions. BrdU Study 3 is
schematically presented in (C); P20d old Tgfbr2-b-Gal-GFP-BAC mice received oral BrdU for 30 days and were sacrificed 52 days
after the last BrdU administration. Three mice were analyzed. (D) Depicts representative sections of Study 3 specimens; 40 · (i–l)
magnifications of interested regions. LacZ-stained dissected digits from both studies were sectioned (sagittal plane) and subjected
to either IHC for BrdU using a peroxidase-based system (see the Materials and Methods section ) (a–l) or (adjacent sections) to
double immunofluorescence (IF) for green fluorescent protein (GFP) and BrdU using Alexa Fluor–based system (see the Materials
and Methods section) (b¢–d¢; f¢–h¢; i¢–l¢). For the IHC studies (a–l), Tgfbr2-b-Gal single LacZ-positive cells are shown in blue; black/
dark brown shows positive cells for BrdU-IHC; blue cells with black/dark brown nuclear indicates BrdU + LacZ double-positive cells
(red arrows). For IF studies (b¢–d¢; f¢–h¢; i¢–l¢) Tgfbr2-GFP single-positive cells are shown in green; red shows BrdU single-positive
cells; yellow indicates BrdU + GFP double-positive cells; DAPI (blue) is used for nuclear counterstaining. IF pictures depict regions
(b¢–d¢; f¢–h¢; i¢–l¢) that were similar to the ones depicted by IHC studies (b–d; f–h; i¢–l¢). Tgfbr2-LacZ/BrdU double-positive cells
localized within specific niches in particular the groove of Ranvier and contiguous synovial-entheseal-articular cartilage complexes
(R1 and R2 marked with red dashed line) of the interphalangeal joints labeling as slow-proliferating cells. Scale bars: 200mm.
‰
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We also found expression within the superficial cells of
tendons and ligaments (arrow 4 in Fig. 5B); synovial regions
outside the synovio-entheseal-articular cartilage complex
(arrow 5 in Fig. 5B) including the synovial lining of the in-
frapatellar fat pad (arrow 6 in Supplementary Fig. S3B); and
the superficial layer of the menisci (arrow 6 in Fig. 5B and
arrow 5 in Supplementary Fig. S3A). We did not notice any
difference of Tgfbr2’s expression between females and males
at any stage (data not shown).
Taken together, our findings show a dynamic and spa-
tiotemporally regulated expression pattern of Tgfbr2 during
joint formation and postnatal life. We found that Tgfbr2 ex-
pression clustered within specific niches that were consistent
throughout early adult life in small and large joints.
Colocalization of Tgfbr2 with joint and progenitor
markers in embryonic interphalangeal joints
We have previously reported that the loss of joint devel-
opment in the Tgfbr2PRX-1KO mouse is associated with the
lack of critical joint morphogenic and joint progenitor marker
expression such as Noggin, GDF5, and Jagged1, indicating
that Tgfbr2 signaling is an upstream mediator essential for
such expression [3]. In this study, we investigated whether
Tgfbr2-expressing cells express those markers. As shown in
Fig. 6 and Supplementary Fig. S4, transversal and sagittal
digital sections were obtained from either E16.5 (Fig. 6) or
E14.5 (Supplementary Fig. S4) LacZ-stained Tgfbr2-b-Gal-
BAC embryos and subjected to IHC for Jagged1, Notch1,
Noggin, GDF5, TGF-b1, TGF-b2, p-Smad2, and Tenascin C.
Data are presented either as unmodified images (left upper
and lower panels related to each IHC study) or after pseu-
docolor image processing (right upper and lower panels re-
lated to each IHC study) to highlight the signals of either
single-stained cells (in blue for single LacZ signal and red for
single IHC-DAB signal) or double-stained cells (in green for
LacZ + IHC signal) (Fig. 6 and Supplementary Fig. S4). For
unmodified images light blue represents single LacZ-positive
signal, light brown presents single IHC-DAB-positive signal,
and dark brown represents double LacZ + IHC-DAB-positive
signal. We found that at E14.5 (red arrows in Supplementary
Fig. S4), the Tgfbr2-b-Gal expression/activity colocalized with
Jagged1, Notch1, and Noggin in both the distal and ventral
sides of the developing joints (consistent with the Domain 1
depicted in Fig. 1) and developing tendons (Supplementary
Fig. S4, red arrows) (consistent with the Domain 2 depicted in
Fig. 1). Tgfbr2 expression colocalized with GDF5 in both the
distal and ventral side of the developing joint (Supplementary
Fig. S4, red arrows). In the middle region of the interzone we
noted expression of Jagged1, Notch1, Noggin, and GDF5, but
not Tgfbr2 (Supplementary Fig. S4). At E16.5 (red arrows in
Fig. 6), the colocalization of Tgfbr2 with Jagged1, Notch1, and
Noggin could still be detected within the same domains;
meanwhile, we found lower expression levels of Jagged1,
Notch1, and Noggin in the middle of the joint (Fig. 6). It is
possible that Tgfbr2 cells regulate expression of those genes
through paracrine as well as autocrine mechanisms. We found
limited colocalization of Tgfbr2 with Tenascin C (Fig. 6 and













R1, 7B(c) 12.0 – 1.0 3.7 – 0.6 20.7 – 0.6 63.0% – 0.6% 85.0% – 1.2%
R2, 7B(d) 20.7 – 0.6 0.3 – 0.6 15.3 – 0.6 43.0% – 0.6% 98% – 0.6%




R2, 7B¢(g) 5.0 – 1.0 8.3 – 0.6 20.0 – 1.6 80.0% – 1.2% 71.0% – 2.1%
R3, 7B¢(g) 0.3 – 0.3 4.0 – 0.0 4.0 – 1.0 93.0% – 2.6% 50.0% – 1.5%
R2, 7B¢(h) 4.6 – 0.3 19.3 – 0.6 18.0 – 1.0 80.0% – 1.6% 48.0% – 1.9%
R3, 7B¢(h) 3.3 – 0.6 2.0 – 0.0 10.0 – 0.3 75.0% – 2.1% 83.0% – 2.0%
R4, 7B¢(f) 2.0 – 0.0 4.0 – 0.0 5.0 – 0.3 71.0% – 2.1%% 56.0% – 1.2%
BrdU Study 2.
P8w + 14d
R1, 8B(b) 16.0 – 1.0 11.0 – 0.0 6.0 – 0.3 27.0% – 0.8% 35.0% – 1.1%
R1, 8B(c) 13.0 – 1.0 4.0 – 1.0 3 – 0.6 18.7% – 3.7% 42.9 % – 8.6%
R2, 8B(d) 11.0 – 1.0 2.0 – 0.0 3.0 – 0.0 7.0% – 0.6% 60.0% – 0.8%
BrdU Study 2.
P8w + 21d
R2, 8B¢(f) 25.6 – 0.6 2 – 0.0 8 – 0.6 23.8% – 2.3% 80.0% – 4.2%
R1, 8B¢(f) 5.0 – 1.0 3.0 – 0.3 1.0 – 0.0 16.6% – 2.3.0% 25.0% – 1.7%
R1, 8B¢(g) 18.0 – 0.6 1.6 – 0.3 4.0 – 0.0 18.2% – 0.5% 71.4% – 4.6%
R2, 8B¢(h) 11.0 – 1.0 2.0 – 0.0 3.0 – 0.0 21.4% – 1.4% 60.0% – 0.0%
BrdU Study 3.
P50d + 52d
R1, 8D(i) 7.0 – 0.6 3.0 – 0.0 2.0 – 0.0 22.2% – 1.4% 40.0% – 0.0%
R2, 8D(i) 4.0 – 0.0 1.0 – 0.3 3.0 – 0.3 42.9% – 2.8% 75.0% – 5.6%
R1, 8D(j) 4.0 – 0.3 4.3 – 0.6 3.0 – 0.0 42.9% – 1.8% 42.9% – 3.4%
R1, 8D(k) 10.0 – 1.0 8.0 – 0.6 4.0 – 0.3 28.6% – 4.0% 33.3% – 3.9%
R2, 8D(l) 5.0 – 0.3 4.0 – 0.6 4.0 – 0.3 44.4% – 4.2% 50.0% – 5.4%
Sections from BrdU Study 1, Study 2, and Study 3 (see text) were analyzed. To quantify single- and double-positive cells, pictures were
taking from slides subjected to LacZ staining and BrdU IHC and then slides were placed into 1 · PBS solution for 20 min to remove the cover
slips and then stained with Fast Red to obtain nuclear staining; single- (either LacZ or BrdU) or double-positive cells and total cells in the
region of interest were counted in six adjacent sections from two mice at each time point. Tgfbr2-LacZ single-positive cells (blue), BrdU-IHC
single-positive (black or dark brown), and LacZ-BrdU double-positive (blue cells with black or dark brown nuclear) cells were counted within
specified regions of interests. Regions of interests are shown in Figs. 7 and 8 to which this table refers. Cells, within the specified region of
interests, were counted in six adjacent sections from two mice at each time point.
BrdU, bromodeoxyuridine; IHC, immunohistochemistry; PBS, phosphate buffered saline.
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Supplementary Fig. S4). TGF-b1 and TGF-b2 are expressed in
developing limbs and TGF-b1 - / - ; TGF-b2 - / - double mutants
show some phenotypic similarities with the Tgfbr2PRX-1KO
mice [3,5]. We found that Tgfbr2 expression colocalizes with
TGF-b1 and TGF-b2 expression although ligands were ex-
pressed in more extensive regions than the receptor (Fig. 6 and
Supplementary Fig. S4).
Taken together, coexpression studies indicate that Tgfbr2-
expressing cells provide a signaling niche to promote joint
development in synchrony with the Noggin, GDF5, and
Notch pathways, corroborating our previous findings that
the Tgfbr2 is needed to regulate expression of these joint
morphogenic factors.
Characterization of Tgfbr2-expressing cells
as slow-proliferating progenitor cells
by BrdU labeling studies
An established method to identify stem cells within dif-
ferent tissues is labeling of slow-cycling cells, namely, the
stem cell population, with BrdU [32]. To determine whether
Tgfbr2 cells are slow proliferating, we performed three dis-
tinct analyses of BrdU incorporation: the first (termed Study
1) aimed at labeling slow-proliferating cells from the em-
bryonic through early postnatal life, the second (termed
Study 2) and third study (termed Study 3) to label postnatal
cells at two postnatal life time points (P6w for Study 2 and
P20d for Study 3) and analyzing BrdU chasing, respectively,
14 and 21 days (Study 2) and 52 days (Study 3) after last dose
of BrdU (Figs. 7 and 8). In Fig. 7, we report BrdU analyses of
Tgfbr2-b-Gal-GFP-BAC mice that received BrdU in the pre-
natal life (given to pregnant mothers from E15.5 to P0)
(Study 1) and sacrificed at P14 and P28. We found that at P14
(Fig. 7B), and even more clearly at P28 (Fig. 7B¢) after BrdU,
the majority of the Tgfbr2-LacZ-positive cells within the
groove of Ranvier (R1) contiguously within the synovio-
entheseal-articular cartilage complexes (R2 and R3) and the
tendons (R4) of the interphalangeal joints were also positive
for BrdU, labeling as slow-proliferating cells; R1, R2, R3, and
R4 regions were marked with a red dashed line. Table 1
reports the quantification of Tgfbr2 single positive (blue
cells), BrdU single positive (cells with black/dark brown
nuclei), and Tgfbr2 + BrdU double positive (blue cells with
black/dark brown nuclei) and their percentage either over
the total of Tgfbr2 single + double positive or over the BrdU
single + double-positive cells within those niches. Twenty-
eight days after BrdU, at least 70% of the Tgfbr2-LacZ-
positive cells were double positive.
For Study 2, we exposed 6-week-old mice to BrdU for 14
days and mice were sacrificed 14 (P8w + 14d = P10w) (Fig.
8B) and 21 days (P8w + 21d = P11w) (Fig. 8B¢) after BrdU
exposure. LacZ-stained dissected digits were sectioned
(sagittal plane) and subjected to either IHC for BrdU using a
peroxidase-based system [Fig. 8B(a–d)] or adjacent sections
[Fig. 8B(b¢–d¢)] to double IF for GFP and BrdU using Alexa
Fluor–based system. We performed GFP (another reporter
gene in Tgfbr2-b-Gal-GFP-BAC mice) and BrdU double IF
analyses to confirm the IHC results of BrdU incorporation
studies. For IHC, Tgfbr2-b-Gal single LacZ-positive cells are
shown in blue; black/dark brown shows positive cells for
BrdU-IHC; blue cells with black/dark brown nuclear indi-
cates BrdU + LacZ double-positive cells (red arrows). For IF
studies [Fig. 8B(b¢–d¢), B¢ (f¢–h¢)] Tgfbr2-GFP single-positive
cells are shown in green; red shows BrdU single-positive
cells; yellow indicates BrdU + GFP double-positive cells;
DAPI (blue) is used for nuclear counterstaining. IF pictures
depict regions [Fig. 8B(b¢–d¢), B¢ (f¢–h¢)] that were adjacently
compatible to the ones depicted by IHC studies [Fig. 8B(b–d),
B¢ (f–h)]. Tgfbr2-LacZ/BrdU localized within specific niches,
in particular the groove of Ranvier and contiguous synovial-
entheseal-articular cartilage complexes (R1 and R2 marked
with red dashed line) of the interphalangeal joints labeling as
slow-proliferating cells. IF analyses [Fig. 8B(b¢–d¢), B¢ (f¢–h¢)]
depicted Tgfbr-2-GFP-BrdU double-positive cells as well as
single cells within the same regions with the same distribu-
tion depicted by LacZ/BrdU staining/IHC [Fig. 8B(b–d), B¢
(f–h)], indicating that the reporter system is robust and
double-staining studies are valid.
For Study 3, we exposed 20-day-old mice to BrdU for 30
days and mice were sacrificed 52 days (P20d + 30d + 52d =
P102d) after BrdU exposure. As shown in Fig. 8D (i–l, re-
spectively, for LacZ-BrdU IHC and i¢–l¢ for GFP-BrdU IF),
Tgfbr2/BrdU double-positive cells were also found in re-
gions that were compatible to the R1 and R2 regions found
for Study 2. Again, IF analyses [Fig. 8D(i¢–l¢)] depicted
Tgfbr-2-GFP-BrdU double-positive cells as well as single
cells within the same regions with the same distribution
depicted by LacZ/BrdU staining/IHC [Fig. 8D(i–l)]. Table 1
reports cell counting data on the double-positive cells.
Study 2 and Study 3 showed similar percentage number of
double-positive cells, with between 50% and 80% of the
Tgfbr2-LacZ-positive cells in the R2 region were found to be
double positive. Taken together, those findings clearly in-
dicate that Tgfbr2-expressing cells are slow-proliferating
progenitors.
Tgfbr2-expressing cells retain the ability to express
joint trait and progenitor markers in postnatal joints
We next assessed whether in adult joints, Tgfbr2-expressing
cells coexpress joint trait markers (GDF5 and Noggin), tendon
markers (Tenascin C), and components of the Notch system
expressed by joint progenitors (Notch1 and Jagged1). IHC
analyses were performed in sections adjacent to the ones in
which IHC for BrdU was performed. Figure 9 (pseudocolor
images) and Supplementary Fig. S5 (unmodified images)
show IHC analyses of P14 and P28 postnatal interphalangeal
joints, indicating that more than 70% of the Tgfbr2-LacZ-
positive cells coexpress traits and progenitor joint markers,
such as GDF5, Noggin, Notch1, and Jagged1. They also co-
express markers of differentiated tendon cells when located
within the specific joint element (ie, Tenascin C in tendons).
Tgfbr2-expressing cells also coexpressed TGF-b1 (Fig. 9 and
Supplementary Fig. S5). These findings in adult joints were
consistent with the findings observed in embryonic studies
(Fig. 6). Similar results were observed when analyses were
performed in 10-week-old mice (data not shown). To further
validate the Tgfbr2-b-Gal reporter system, we performed IHC
for p-Smad2 at P14, P28 and found that all the LacZ-positive
cells were also positive for p-Smad2 (Fig. 9 and Supplemen-
tary Fig. S5). Taken together, these results demonstrate that
joint Tgfbr2-expressing cells localize within specific niches
where they label as slow-proliferating cells and express joint
markers.
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FIG. 9. Tgfbr2-expressing cells retain the ability to express Jagged1, Notch1, Noggin, GDF5, TGF-b1, TGF-b2, and Tenascin
C in postnatal interphalangeal joints. Forelimbs from P14- and P28-old Tgfbr2-b-Gal-GFP-BAC mice were LacZ stained,
sagittal sections obtained, and adjacent sections subjected to IHC using antibodies against p-Smad2 (B), TGF-b1 (C), Notch1
(D), Jagged1 (E), Noggin (F), GDF5 (G), and Tenascin C (H). Immunostaining was visualized using a peroxidase-based
system (IHC-DAB). Images were subjected to pseudocolor imaging process as described in the Materials and Methods
section. Light blue indicates single LacZ-positive signal; yellow indicates IHC-DAB signal and green indicates double staining
signal. (A) 10 · magnifications of, respectively, P14 (left panel) and P28 (right panel) identifying the regions (R1, R2, and R3)
that are shown as 40 · magnifications, respectively, in the left panel (R1), middle panel (R2), and left panel (R3) in the (B) to (H)
images. Red arrows indicate regions of double-positive cells. Studies were performed in at least two sections for each antibody
obtained from at least two mice at each time point. Scale bars: 200 mm.
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Isolation and characterization of joint
Tgfbr2-expressing cells
Our data have so far indicated that Tgfbr2-expressing
cells are highly restricted to specific areas that are main-
tained throughout adult life; within those niches, cells ex-
press joint and progenitor/stem cell markers and are slow
proliferating. This remarkable consistency led us to deter-
mine: (1) whether isolated Tgfbr2-positive cells express the
same repertoire of genes we found by histological analy-
ses; (2) whether such expression are regulated through
critical stages of joint development; and (3) the effects of
FIG. 10. Isolated Tgfbr2 joint progenitor cells express markers of differentiated joint elements while maintaining expression
of joint progenitor markers. Expression is regulated by development and the activation of the TGF-b signaling. Distal tips of
autopods from either E13.5 or E14.5 Tgfbr2-b-Gal-GFP-BAC embryos were dissected and subjected to enzymatic digestion to
obtain single-cell mesenchyme populations. Cells were subjected to GFP-based fluorescence-activated cell sorting (FACS)
sorting. (A) Depicts the comparative gene expression profile of Tgfbr2-positive cells isolated from either E13.5 or and E14.5
autopod mesenchyme. mRNA obtained from freshly isolated Tgfbr2-positive cells was analyzed by quantitative real-time
polymerase chain reaction. (B) Depicts the comparative gene expression profile of isolated TgfbR2-expressing cells in re-
sponse to TGF-b1. mRNA was obtained from cells cultured with or without TGF-b1 (20 ng/mL) for 16 h. Expression of target
gene was normalized to GAPDH expression. Samples were obtained from two experiments and run in triplicates; data were
analyzed using the 2 -DDCT method and expressed as fold of increases compared with the average of either the E13.5 (A) or
untreated sample (B), which was given the arbitrary value of 1. (*) P < 0.05 Student’s t-test.
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TGF-b on isolated cells. For this purpose mesenchyme cells
obtained from the digits of E13.5 and E14.5 Tgfbr2-b-Gal-
GFP-BAC embryos were subjected to GFP-based FACS
sorting to obtain Tgfbr2-positive cells. We have generally
obtained *200,000 positive cells from five to seven em-
bryos and positive fraction has been 0.97% – 0.17% (n = 3)
from E13.5 embryos and 1.62% – 0.25% (n = 3) from E14.5
(Supplementary Fig. S6). The interval between E13.5 and
E14.5 is critical in joint development; at E13.5 the interzone
develops and by E14.5 the forming joint segments from the
adjacent growth plates. These rapid anatomic changes are
associated with a rapid change in joint morphogenic
marker gene expression [33]. As shown in Figs. 1 and 2,
Tgfbr2 expression within the joint is minimal at E13.5 with
a rapid expansion at E14.5 where it occupies the domains
where it will be maintained throughout adulthood. This
observation led us to perform comparative gene expression
profiling of Tgfbr2-positive cells obtained at E13.5 versus
cells obtained at E14.5. As shown in Fig. 10, we found that
when compared to Tgfbr2-positive cells obtained at E13.5,
cells obtained at E14.5 expressed higher levels of trait joint
genes (Notch1, GDF5, Noggin, Collagen 1, Gli3, Sulf1, and
Wnt9a), differentiated joint element cell marker genes, in-
cluding articular cartilage (Collagen 2) and tendon marker
genes (Scleraxis and Tenascin C) and synoviocyte marker
genes (Lubricin). A population of joint interzone cells has
been recently identified based on the negative expression
of Matrilin 1 [34]. We found that in Tgfbr2-positive cells
either from E13.5 or E14.5 embryos, Matrilin 1 was un-
detectable. To determine the responsiveness of Tgfbr2-
positive cells to TGF-b1, cells isolated from E14.5 digits
were cultured with TGF-b1 for 16 h. We found that cells
responded to treatment by increasing joint trait and pro-
genitor markers such as Notch1, GDF5, Noggin, and
Sulf1, articular cartilage markers such as Aggrecan, tendon
markers such as Scleraxis and Tenomodulin, and syno-
viocyte markers such as Lubricin (Fig. 10). We found that
TGF-b1 treatment led to a decrease of Tgfbr2, Collagen I,
Wnt9a, and Collagen II (Fig. 10).
The isolation from synovium of potential joint progeni-
tors/stem cells has been reported and those cells express
some of the MSC markers [26,35,36]. Therefore, we evaluated
in Tgfbr2-positive cells the expression patterns of gene
markers for MSCs. We found that Tgfbr2-positive cells ex-
press several MSC markers; remarkably, we found that 100%
of cells express CD29 (Supplementary Fig. S7). As expected,
Tgfbr2 cells were negative for CD34, CD11b, and CD45,
markers of adult hematopoietic cells (Supplementary Fig.
S7). Taken together, our data indicate that we have identified
and isolated Tgfbr2 joint progenitor cells that can express
markers of differentiated joint elements while maintaining
joint progenitor marker expression and such expression is
regulated by the activation of TGF-b signaling.
Discussion
In the present study we have identified and character-
ized a population of joint cells with the unique signature
of Tgfbr2 expression, a gateway receptor in joint devel-
opment. We found that within the interphalangeal joints,
Tgfbr2-expressing cells localize into specific niches com-
prising the groove of Ranvier and the contiguous synovio-
entheseal-articular cartilage complex. These niches are
consistently maintained from the time of interzone devel-
opment to early adulthood. Tgfbr2-expressing cells were
found in the synovio-entheseal complex niche with similar
temporal pattern in the knee, where they were also de-
tected in meniscal surface, ligaments, and the synovial
lining of the infrapatellar fat pad. Within these niches, the
Tgfbr2-expressing cells coexpress joint morphogenic and
progenitor/stem cell markers and have a slow-proliferative
trait. Tgfbr2-expressing cells isolated from embryonic digits
express joint progenitor as well as terminally differentiated
joint markers and expression are development dependent
as well as TGF-b dependent.
Identification and, most importantly, functional charac-
terization of joint progenitors have been a challenge.
During development, we have limited knowledge of spe-
cific markers for interzone cells and in postnatal joints, we
lack information on whether these cells maintain expres-
sion of embryonic markers and their contribution to joint
homeostasis. Most of the studies that track joint progeni-
tors have been based on knock-in lineage tracing strategies
that led to the identification of Matrilin-1 (negative) and
GDF5 (positive) interzone expressing cells [12,34]. Al-
though powerful, this strategy carries the disadvantage of
the irreversible activation of the reporter activity that tags
the cell and its progenies indefinitely and thus impedes the
possibility of determining the cell–cell temporal expression
pattern. By generating the Tgfbr2-b-Gal-GFP-BAC mice, we
were able to determine the real-time expression pattern of
Tgfbr2-expressing cells, their ontogeny from the time of
interzone development to adulthood and their temporally
and spatially consistent localization within specific niches.
Further, our studies uniquely look into the expression of
Tgfbr2, a gene that is essential for joint development as
indicated by the loss of interzone development and joint
morphogenic marker expression in the Tgfbr2PRX-1KO
mouse [3]. In contrast, Matrilin-1 is not essential for joint
development and Matrilin-1 knock-out mice do not show
any overt skeletal phenotype [37]. The brachypodism
mouse carrying null-sense mutations for GDF5 has limited
joint abnormalities [6]. Further, ectopic GDF5-Cre expres-
sion has been raised as a concern in the Gdf5-Cre mice
used to perform lineage-tracing for GDF5-expressing joint
progenitors [12,38].
The interzone is an essential signaling center for joint de-
termination although the contribution of the interzone cells
to the development of joint elements remains to be deter-
mined. Further the cellular organization varies among spe-
cies, making comparative analyses difficult. In fact in the
chick, the interzone consists of three distinct layers, while in
humans and rodents, only a thin flattened layer is identified
[39,40]. Another important question is the primary source of
articular cartilage cells. One school of thought favors the idea
that they are derived from the flattened interzone cells while
another from the epiphyseal growth zone [12,34]. Studies
have not led to clear conclusions because they either relied
on the lack of a phenotypic trait (Matrilin-1) and/or cells
could not be monitored for emergence over time [12,34]. Our
data provide novel means to understand the organization
and the fate of the interzone cells. We found that within the
interzone, Tgfbr2-expressing cells localize in the dorsal re-
gion of the developing interzone (Domain 1 in Fig. 2) and
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this domain extends and is retained through early adult-
hood. Tgfbr2-expressing cells show in vivo and in vitro
developmental plasticity as they express markers of differ-
entiated joint elements along with joint progenitor markers
and TGF-b modulates such plasticity. Our data support a
novel hypothesis for interzone development, in which the
Tgfbr2-expressing cells play an essential role as progenitors
that orchestrate joint development within specified niches. It
also supports the concept, proposed by others but not fully
sustained by conclusive data, for a common progenitor for
the distinct joint elements as supported by the cell expression
profile of the Tgfbr2 cells, their in vitro differentiative
plasticity and the lack of several joint elements in the
Tgfbr2PRX-1KO mouse.
Our studies have been primarily focused on determining
the in vivo progenitor/stem cell nature of Tgfbr2-expressing
cells by BrdU analysis, expression profiling, and histologi-
cal/anatomical localization within niches. Our in vitro
studies in freshly isolated cells have extended and/or con-
firmed the gene expression profiling of the cells and evalu-
ated responsiveness to TGF-b in short-term (16 h) primary
cultures. We recognize that freshly isolated or primary
cultured cells can represent a mixed population of Tgfbr2-
expressing cells and future in vitro studies on clonally ex-
panded cells and lineage differentiation assays would be
exciting and provide additional information on the stemness
of the cells. We also recognize that such in vitro studies have
limitations such that culturing condition and passaging
would not necessarily prove and may actually alter the
stemness that occurs within the natural niche that has been
addressed by our in vivo studies.
We have used different means to validate the Tgfbr2 ex-
pression pattern detected by LacZ staining in Tgfbr2-b-Gal-
GFP-BAC mice. Our results indicate that the system seems to
be consistent and robust; we recognize that new antibodies
and probes can be generated for further validation and to
determine the endogenous expression of Tgfbr2. We have
previously reported IF and ISH studies that detected Tgfbr2
expression at the joints and those data have been confirmed
in the current study that also shows that those regions are
detected by LacZ staining in Tgfbr2-b-Gal-GFP-BAC mice as
well as by IHC for p-Smad2 [3]. However, we have noted
additional signals detected by immunostaining and ISH for
Tgfbr2. Those signals are most likely not specific as indicated
by their persistence in the Tgfbr2Prx1KO and the lack of
overlapping with p-Smad2 immunodetection, indicating that
immunostaining and ISH detection using these Tgfbr2 anti-
body and probe seem to be sensitive but not specific. Over
the past several years our laboratory has tried several anti-
bodies for IHC and IF and probes for ISH to detect the Tgfbr2
expression, although the ones showed are the finest in term
of sensitivity we are still not satisfied with the results. This
poor specificity (noted by other investigators) was one of
reasons that led us to generate the Tgfbr2-b-Gal-GFP-BAC
mouse.
Our data provide novel evidence for a cohort of joint
cells that continue to express Tgfbr2 within specific niches
throughout sexual maturity and in a time-dependent
manner. It is possible that the Tgfbr2-expressing cells are a
different cell population that emerges over the lifespan of
the organism. However, the consistent topographical ex-
pression profile when evaluated at close time points makes
this possibility unlikely. In recent years, the identification
of progenitor cells within adult joint elements has funda-
mentally challenged the dogma of joints and in particular
articular cartilage as a postmitotic tissue. Progenitors have
been identified within the articular cartilage as slow-
cycling cells [9,41,42]. Isolation of presumptive articular car-
tilage progenitors has been based on fibronectin adhesion
and positive expression for Notch1 and chondroitin sul-
fate sulfation motifs [9–11,35]. Joint progenitors have also
been isolated from infra-patellar fat pad and the synovium,
the latter having been shown to express MSC markers
[10,14,26,35,36]. Despite these encouraging in vitro studies,
the ability of adult joint progenitors to express differenti-
ated joint element markers while maintaining slow-cycling
trait has never been proven in vivo. In our studies, we
identified native niches for Tgfbr2-expressing cells and in
two distinct BrdU studies we have characterized that
within those niches, the Tgfbr2-expressing cells are slow
proliferating and express markers of progenitors as well as
differentiated joint elements. Stem cells/progenitors are
generally found to reside in niches that provide the cel-
lular and extracellular environment to orchestrate the
timing and levels of signals that stem cells receive, thus
directing their fate over contrasting cell-fate decisions such
as self-renewal or differentiation. Joint formation is a fast
and dynamic process where development and rearrange-
ment occur in a well-defined time and space frame; on the
other hand, adult joints have limited regenerative abilities.
Our studies identified Tgfbr2-expressing cells that were
maintained within specific niches from embryonic life
throughout early adulthood although characterized by a
progressive age-dependent reduction in number. This is an
important finding that confirms the existence of joint
progenitor cells in adulthood, highlights the persistence
from prenatal to postnatal life, and outlines the decline
with aging. The identification of Tgfbr2 adult joint pro-
genitors opens the prospects for potential ways to re-
activate the joint-forming abilities of those cells, to
implement their survival during aging, and to evaluate
their role in arthritic degeneration.
The identification of the Tgfbr2-expressing cells within the
groove of Ranvier and the contiguous synovio-entheseal-
articular cartilage complexes is intriguing. Recent studies
based on BrdU incorporation in mature rabbits have identi-
fied the groove of Ranvier as a niche for joint progenitors
[13]. We have determined that the slowly proliferating cells
within the groove of Ranvier and the contiguous synovio-
entheseal-articular cartilage complexes specifically express
Tgfbr2 and coexpress GDF5, Noggin, Notch1, and Jagged1.
Within these niches, Tgfbr2-expressing cells localize in the
superficial layers of the articular cartilage, tendons, and sy-
novial, sites where progenitors of these joint elements have
been identified [9,26,43]. Whether the slow-proliferating-
Tgfbr2-expressing cells represent a reservoir of stem cells for
the articular cartilage, synovium, and tendon progenitors
needs to be determined. The proximity to those niches makes
the migration process plausible and the in vitro studies may
indicate such plasticity.
Shapiro et al. have morphologically identified three layers
for the groove of Ranvier, a deeper layer of densely packed
cells adjacent to the growth plate, an intermediate layer of
more widely dispersed cells, and a superficial fibrous layer of
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fibroblast-like cells and collagen fibers [16]. As stated by the
same authors, this layer-based terminology is in accordance
with the terminology used by Ranvier that first described the
groove [19]. Through postnatal development the layers be-
come part of the periosteum [18]. The biological functions of
the morphologically identified cells within the layers still
remain elusive. Interestingly, we noted that within the
groove, the Tgfbr2-expressing cells can be found in different
layers of the groove, either in the deeper and outer (Fig. 4), or
in all the layers (Fig. 6). Localization within the layers does
not appear to be specific for a particular joint and we cannot
exclude that can be related to the angle of sectioning even
within the same plane. In future studies it will be interesting
to determine whether the localization of the Tgfbr2-expres-
sing cells within the layers of the groove is related to a
specific function.
The concept of synovio-entheseal-articular cartilage com-
plex comes from the clinical observation that in patients with
OA and spondylarthritis the sites where enthesis, synovium,
and articular cartilage converge are all subjected to inflam-
mation, therefore leading to the concept of arthritis as ‘‘an
organ’’ disease [20]. This relatively old concept has re-
emerged and has been strengthen by recent magnetic re-
sonance imaging studies that have shown that synovitis and
enthesitis can occur early in the OA process at a stage when
the articular cartilage appears relatively normal [21]. The
concept of arthritis as an ‘‘organ disease’’ has led to the hy-
pothesis of a common mechanism that links the pathological
process and affects different tissues at sites of crossroads [20].
The finding of a defined niche for a Tgfbr2 stem population
within the synovio-entheseal-articular cartilage complex
raises the fascinating possibility of a stem cell disease as a
pathogenic mechanism in the arthritic process. Future stud-
ies are needed to further explore this hypothesis.
Functions of specific cell populations can be inferred
from (1) in vivo studies either based on conditional knock-
out of genes specifically expressed by the targeted cell
population or aimed at determining a cell function, that is,
slow-proliferating trait; (2) histological/imaging studies in
which the cells expressing specific markers are identified
within specific tissues; and (3) direct isolation and in vitro
studies of the cells themselves. We have used all three
approaches to characterize the roles and functions of Tgfbr2
in joints. In our previous studies we found that the condi-
tional knock-out of Tgfbr2 in developing limb mesenchyme
leads to lack of interphalangeal joint formation as well as
lack of knee tendons and menisci [3,4]. The present studies
provide direct evidence of Tgfbr2-expressing cells as joint
progenitors describing their niches, slow-proliferative pro-
file, and plasticity. The latter was assessed using primary
cultures of isolated Tgfbr2-positive cells from digital mes-
enchyme. Our data show that Tgfbr2-positive cells have the
dual capacity to express progenitor markers, such as
Notch1, and initial joint trait markers, such as GDF5, Gli3,
and Wnt9a, while they can be steered by TGF-b treatment
and developmental growth to express chondrocyte (ag-
grecan), synoviocyte (lubricin), and tenocyte (scleraxis)
markers. This plasticity represents a major asset of the
Tgfbr2-positive cells, as pointed out above the cells can
function as the initiators of distinct joint elements and po-
tentially give rise to chondrogenic, ligaments/tendons, and
synovial lining cellular elements. It is interesting to note
that TGFb-treatment led to a decrease of Tgfbr2 expression
while also decreasing some of the chondrogenic markers
such as Collagen 2. We hypothesize that TGF-b is a critical
factor to steer the cells into distinct developmental pro-
grams while controlling Tgfbr2 expression. Joint progenitors
have been reported to express adult MSC markers [26,36].
Interestingly, we also found that Tgfbr2-positive cells ex-
press several MSC markers reinforcing the concept of
Tgfbr2 cells as mesenchymal progenitor.
In conclusion, we have provided evidence that Tgfbr2-
expressing cells have anatomical, ontogenic, slow-cycling
proliferative trait and in vivo and in vitro expression profile
of progenitor joint cells. The identification of this novel
population of joint progenitors provides insights not only to
the understanding of joint development but also opens
novel prospective to the study and treatment of the arthritic
process.
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